NCT01648153 Investigate the Efficacy and Safety of GSK1070806 in Obese Subjects With T2DM Status COMPLETED Phase PHASE2
NCT01648101 Assessment of the Efficacy and Safety of 2 Doses of Retigabine Immediate Release (900 mg/Day and 600 mg/Day) Used as Adjunctive Therapy in Adult Asian Subjects With Drug-resistant Partial-onset Seizures Status TERMINATED Phase PHASE3
NCT01647659 Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation Status COMPLETED Phase PHASE1
NCT01642173 Assessment of Coronary Plaque Composition Using Optical Coherence Tomography Status COMPLETED Phase PHASE1
NCT01641809 Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine Status COMPLETED Phase PHASE2
NCT01641692 A 3-period Crossover Study With GSK573719 as Monotherapy in Adult Subjects With Asthma Status COMPLETED Phase PHASE2
NCT01641237 Effect of Fluoride in a Dentifrice on Remineralization of Erosive Lesions Status COMPLETED Phase PHASE3
NCT01641133 Primary Vaccination With Either Synflorix™ or Prevenar 13™ or Both Vaccines and Booster Vaccination With Synflorix™ Status COMPLETED Phase PHASE3
NCT01641042 Comparison of GlaxoSmithKline (GSK)134612 in Subjects With Increased Risk for Meningococcal Disease Versus Healthy Subjects Status COMPLETED Phase PHASE3
NCT01640990 A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of an Intravenous Infusion of GW328267X in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01639339 Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis Status COMPLETED Phase PHASE3
NCT01636778 Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients Status COMPLETED Phase PHASE2
NCT01636726 WEUKBRE5554: IMI PROTECT(Work Package 2): Beta2 Agonists and Acute Myocardial Infarction Status COMPLETED Phase N/A
NCT01636713 A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD Status COMPLETED Phase PHASE3
NCT01636271 SB-480848 in Major Adverse Cardiovascular Events - Integrated Summary of Efficacy and Safety From the STABILITY Trial (LPL100601) and the SOLID-TIMI-52 Trial (SB-480848/033) Status COMPLETED Phase N/A
NCT01632241 Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) Status COMPLETED Phase PHASE4